Duloxetine 30 MG
Sponsors
Gamal Mohamed Taha Abouelmagd, Mayo Clinic, Assiut University, Hawler Medical University, Wake Forest University Health Sciences
Conditions
Breast CancerCancer PainChemotherapy-induced Peripheral NeuropathyDepressionDepression in Old AgeFibromyalgiaFragility FractureInterstitial Lung Disease
Phase 2
Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough
RecruitingNCT05110144
Start: 2021-11-01End: 2026-12-01Target: 50Updated: 2026-01-21
Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
RecruitingNCT05120934
Start: 2021-11-01End: 2026-10-01Target: 25Updated: 2026-01-21
Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
CompletedNCT05486026
Start: 2022-08-20End: 2023-01-02Updated: 2023-03-14
Phase 4
Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures
RecruitingNCT05851898
Start: 2024-04-08End: 2028-12-01Target: 100Updated: 2026-03-12
Identifying and Treating Depression in the Orthopaedic Trauma Population
RecruitingNCT05976347
Start: 2025-06-25End: 2026-05-31Target: 100Updated: 2025-07-28
Unknown Phase
Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients
CompletedNCT04732455
Start: 2021-01-15End: 2022-07-05Updated: 2022-07-11
Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain
CompletedNCT05311774
Start: 2022-04-01End: 2025-10-01Updated: 2025-12-03
The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia
CompletedNCT05937711
Start: 2020-11-02End: 2022-05-23Updated: 2023-07-10